Promethera Biosciences SA
Ouverture de faillitePromethera Biosciences reported total assets of €4.34m at the end of the 2022 financial year (non-consolidated annual accounts filed with the NBB on 07 Jul 2023).
The score of Promethera Biosciences shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2022
Change 2019 → 2022: Total assets -91 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Promethera Biosciences's annual accounts
Filed annual accounts
- Year ended 31 Dec 2022filed on 07 Jul 2023
- Year ended 31 Dec 2021filed on 05 Aug 2022
- Year ended 31 Dec 2020filed on 23 Jun 2021
- Year ended 31 Dec 2019filed on 29 Jul 2020
- Year ended 31 Dec 2018filed on 03 Jun 2019
Promethera Biosciences's financial analysis
- Solvency-34.5%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Promethera Biosciences
Promethera Biosciences's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0809.788.365
- VAT number
- BE0809788365
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 12 Feb 2009
- Registered office
- 1435 Mont-Saint-Guibert
- Latest accounts
- 2022 · filed on 07 Jul 2023
- Activity
- Activities in the field of nutrition (NACE 86995)
Promethera Biosciences (SA) has been based in Mont-Saint-Guibert since 2009, active in: activities in the field of nutrition. For 2022, it reports a net loss of 519,541 € and equity of −€1.50m; its revenue is not published. Its solvency stands at -34.5%, below the median of its sector (58.4%).
Companies similar to Promethera Biosciences
Companies in the same business, of comparable size and area, outside its group.
- Dr. Peter Vandergoten, Cardiologie Other human health activities n.e.c. Overijse · balance sheet €3.08m
- Dr. Marc Van De Sande - Dr. Adelheid Vanderstappen Other human health activities n.e.c. Lummen · balance sheet €2.22m
- Docteur Fabienne Liénart Other human health activities n.e.c. La Louvière · balance sheet €1.10m
- Bylan Other human health activities n.e.c. Esneux · balance sheet €1.06m
- Europees Economisch Samenwerkingsverband Voor Homeopathischeen Antroposofische Medische Producten Other human health activities n.e.c. Brussels · balance sheet 152,210 €
- NK Consult Other human health activities n.e.c. Brussels · balance sheet 2,878 €
- Vandevelde LUC Other human health activities n.e.c. Eeklo · balance sheet €2.58m
- DR. Verbuyst Roel Other human health activities n.e.c. Antwerp · balance sheet €2.00m
Frequently asked questions about Promethera Biosciences
What is the revenue of Promethera Biosciences?
Promethera Biosciences files its accounts in a format where revenue is optional: it is not published for 2022.
What is the VAT number of Promethera Biosciences?
In Belgium, the VAT number is the company number prefixed with BE: BE0809788365 for Promethera Biosciences, if the company is VAT-registered. Its company number (CBE) is 0809.788.365.
Where is the registered office of Promethera Biosciences?
According to the CBE register, the registered office of Promethera Biosciences is in 1435 Mont-Saint-Guibert.
What is the equity of Promethera Biosciences?
At the close of the 2022 financial year, the equity of Promethera Biosciences amounts to -1,496,032 €, a solvency of -34.5% of total assets.
Who manages Promethera Biosciences?
The register lists 6 active mandates at Promethera Biosciences. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Promethera Biosciences
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →